XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.1
ORGANIZATION AND NATURE OF OPERATIONS (Details Narrative)
9 Months Ended
Jan. 13, 2023
USD ($)
Dec. 30, 2022
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
Jun. 30, 2022
USD ($)
Apr. 13, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 07, 2021
USD ($)
Jun. 30, 2021
USD ($)
Jan. 07, 2021
USD ($)
Jan. 07, 2021
CNY (¥)
Jul. 23, 2020
USD ($)
Jul. 23, 2020
CNY (¥)
May 05, 2019
Mar. 13, 2019
USD ($)
Mar. 13, 2019
CNY (¥)
Oct. 26, 2017
Sep. 30, 2017
USD ($)
Sep. 30, 2017
CNY (¥)
Dec. 10, 2016
USD ($)
Dec. 10, 2016
CNY (¥)
Jul. 14, 2006
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Registered capital     $ 42,568,191 $ 40,326,517 $ 37,428,382 $ 33,312,888   $ 41,834,442   $ 45,378,206                          
Payments to acquire businesses, gross     $ 9,000,000                                      
Changzhou Biowin Pharmaceutical Co Ltd [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Business acquisition, percentage   51.00%                                          
Payments to acquire businesses, gross   $ 9,000,000                                          
Shares issued | shares   3,260,000                                          
Share price | $ / shares   $ 0.001                                          
Dream Ltd [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Business acquisition, percentage 80.00%                                            
Purchase price acquisition, value $ 40,000,000                                            
Xinjiang Taihe [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Registered capital                                     $ 1,500,000 ¥ 10,000,000.0      
Runze [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Registered capital                                     $ 1,500,000 ¥ 10,000,000.0      
Tianjin Tajite [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Registered capital                                         $ 2,100,000 ¥ 14,000,000  
Tenjove Newhemp Biotechnology Co., Ltd [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Registered capital                               $ 1,500,000 ¥ 10,000,000.0            
Shanghai Jiaying International Co Ltd [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Registered capital                         $ 29,900,000 ¥ 200,000,000                  
Inner Mongolia Shineco Zhonghemo Biotechnology Co Ltd [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Registered capital                     $ 7,500,000 ¥ 50,000,000                      
Life Science [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Registered capital                 $ 10,000,000.0                            
Life Science Group Hong Kong Co [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Registered capital             $ 10,000,000.0                                
Tenet Jove Technological Development Co Ltd [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Equity ownership interest percentage                                             100.00%
Tianjin Tenet Technological Development Co Ltd [Member] | Tenet Jove Technological Development Co Ltd [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Equity ownership interest percentage                                             90.00%
Tianjin Tajite [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Equity ownership interest percentage           77.40%                 26.40%     51.00%     51.00% 51.00%  
Shanghai Jiaying International Co Ltd [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Equity ownership interest percentage                         90.00% 90.00%                  
Inner Mongolia Shineco Zhonghemo Biotechnology Co Ltd [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Equity ownership interest percentage                     55.00% 55.00%                      
Life Science Group Hong Kong Co [Member] | Share Transfer Agreement [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Equity ownership interest percentage             100.00%                                
Chongqing Wintus Group [Member]                                              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                              
Equity ownership interest percentage 100.00%